Peer-reviewedCC BYCancers
The Rationale for Tissue Biopsy in the Era of Precision Hepatocellular Carcinoma Management
4 affiliations
- 1Pathology Department, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45500 Ioannina, Greece
- 2Department of Pathology, Aretaeion Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece
- 34th Department of Internal Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
- 4Second Department of Internal Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
Related
- Adjuvant and Perioperative Systemic Therapy for Resectable Hepatocellular Carcinoma: Evidence, Biological Rationale, and Trial Design
- DUBHE-H-308 study protocol: rationale and adaptive design of a randomized, open-label, seamless phaseII/III trial of iparomlimab and tuvonralimab (QL1706)-based regimens versus sintilimab plus bevacizumab as first-line treatment for advanced hepatocellular carcinoma
- Precision surgical oncology for hepatocellular carcinoma
- Normal-Tissue Absence, Rather Than Cross-Patient Prevalence, Limits a Fixed Splice-Junction Panel in Hepatocellular Carcinoma: From a Pre-Specified In Silico Screen to a Genome-Wide Analysis
- Solitary Skull Metastasis as Initial Presentation of Hepatocellular Carcinoma: A Rare Case Report and Management Review
BibTeX
@article{grypari2026rationale,
title = {{The Rationale for Tissue Biopsy in the Era of Precision Hepatocellular Carcinoma Management}},
author = {Ioanna-Maria Grypari and Dina G. Tiniakos and Maria Kalafateli and Eleni Theocharidou},
journal = {Cancers},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13664514},
note = {CC BY},
}
RIS
TY - JOUR
TI - The Rationale for Tissue Biopsy in the Era of Precision Hepatocellular Carcinoma Management
AU - Ioanna-Maria Grypari
AU - Dina G. Tiniakos
AU - Maria Kalafateli
AU - Eleni Theocharidou
PY - 2026
DA - 2026/09/25
JO - Cancers
UR - https://europepmc.org/article/PMC/PMC13664514
SN - 2072-6694
ER -